We are live on ! Find out more
AHG

Akso Health Group

5 hedge funds and large institutions have $224K invested in Akso Health Group in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% less ownership

Funds ownership: 0.05% → 0.04% (-0.01%)

10% less capital invested

Capital invested by funds: $248K → $224K (-$24K)

38% less funds holding

Funds holding: 8 → 5 (-3)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
5
Holders Change
-3
Holders Change %
-37.5%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

AHG Hedge Fund Activity: Q2 2025 in Review

5 of the 7,616 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q2 2025, worth a combined $224K — down 9.7% from $248K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of AHG and 0 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $7.13K. The largest seller was Millennium Management, exiting entirely with an estimated $27.9K sold.

  • 5 institutional investors held Akso Health Group (AHG) as of Q2 2025, down from 8 in Q1 2025.
  • Funds reported $224K of Akso Health Group stock for Q2 2025, down 9.7% quarter-over-quarter.
  • 0 funds opened new Akso Health Group positions in Q2 2025 and 3 closed out, a net change of -3 holders.
  • The largest Akso Health Group buyer in Q2 2025 was UBS Group, an estimated $7.13K added.
  • The largest Akso Health Group seller in Q2 2025 was Millennium Management, an estimated $27.9K sold.

Based on aggregated 13F filings for Q2 2025.